Rational design of shepherdin, a novel anticancer agent
Janet Plescia(University of Massachusetts Chan Medical School), Dario C. Altieri(The Wistar Institute), Paola Fortugno(University of Massachusetts Chan Medical School), Massimiliano Meli(Institute of Chemistry of Molecular Recognition), Marzia Pennati(Fondazione IRCCS Istituto Nazionale dei Tumori), Dmitry I. Gabrilovich(AstraZeneca (Netherlands)), Giorgio Colombo(University of Pavia), Takehiko Dohi(Penn State Milton S. Hershey Medical Center), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Whitney Salz(University of Massachusetts Chan Medical School), Yulia Nefedova(The Wistar Institute), Fang Xia(University of Massachusetts Chan Medical School), Maria Grazia Daidone(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 347
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
|Cell|2011|1.4k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
|Journal of Clinical Investigation|2015|1k